Genetic KO or antibody inhibition of P53 could alleviate G2/M arrest and significantly relieve renal fibrosis level in acute kidney injury model (41), indicating that the P53 signaling pathway might be a target for AAI treatment. Here, TP53 is linked to acute kidney injury.